Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Nature|November 22, 2017
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillanceJinfang Zhang, Xia Bu, Haizhen Wang, et al.
EMBO Molecular Medicine|December 7, 2020
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancerWeiqiang Lu, Weiwei Yu, Jiacheng He, et al.
Gigascience|March 23, 2017
RED-ML: a novel, effective RNA editing detection method based on machine learningHeng Xiong, Dongbing Liu, Qiye Li, et al.
Molecular Cancer|November 28, 2019
Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assemblyQing Shi, Yasheng Zhu, Jian Ma, et al.
Nature Genetics|April 1, 2025
Spatially resolved transcriptomic analysis of the adult human prostateJunyi Hu, Fei Liu, Jing Zhang, et al.
European Radiology|November 19, 2023
Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysisJianglei Ma, Qinqin Yang, Xiaofei Ye, et al.
Cell Reports|April 13, 2016
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate CancerYu Zhao, Liguo Wang, Shancheng Ren, et al.
Asian Journal of Urology|December 22, 2017
Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer ConsortiumRui Chen, Liping Xie, Xiaobing Cai, et al.
Nature Communications|October 8, 2015
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancerMeilin Wang, Atsushi Takahashi, Fang Liu, et al.
Developmental Cell|January 1, 2019
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer ProgressionJinfang Zhang, Ming Chen, Yasheng Zhu, et al.
Pageof 11